Wall Street Journal: Health-Care VCs Take Aim at High Drug Prices

With drug prices climbing, startups are stepping in to ease the pharmacy benefits burden for employers and consumers. CEO Faisal Mushtaq shares his insights on how Truveris is leading the industry by providing more transparency to drug pricing.

Don't see the article? Click here to open in a new window.

Topics: News

Posted by

Truveris Team